Læknaneminn - 01.04.1990, Blaðsíða 53

Hanahan D (1989). Using transgenic mice as probes of
complex systems. Science: 246; 1265-74.
Herzog C et al. (1987). Monoclonal anti-CD4 in arthritis.
Lancet: 2; 1461-2.
Janeway CA(1989). Autoimmunedisease: Immunotherapy
by peptides? Nature: 341; 482-3.
Lo D (1990). Immune responses to tissue-restricted self
antigens: Studies on T cell tolerance and autoimmunity to
pancreatic betacells. CurrTop Microbiol Immunol: 164; 71 -
94.
MacLaren NK (1988). How, when and why to predict
IDDM. Diabetes: 37; 1591-4.
Mathieson PW et al. (1990). Monoclonal-antibody therapy
in systemic vasculitis. N Engl J Med: 323; 250-4.
Mueiler DL, Jenkins MK, Schwartz RH (1989). Clonal
expansion versus functional clonal inactivation; a
costimulatory pathway determines outcome of T cell antigen
receptor occupancy. Ann Rev Immunol: 7; 445-80.
Roman L et al. (1990). The expression of influenza virus
hemagglutinin in the pancreatic 6 cells of transgenic mice
results in autoimmune diabetes. Cell: 61; 383-96.
Sarvetnick N et al. (1988). Insulin dependent diabetes
mellitus induced in transgenic mice by ectopic expression of
class II MHC and interferon-gamma. Cell: 52; 773-82.
Schwartz RH (1989). Acquisition of immunological self-
tolerance. Cell: 57; 1073-81.
Sigurdsson E og Bækkeskov S (1990). The 64kD B cell
membraneautoantigenandothertarget moleculesofhumoral
autoimmunity in IDDM. CurrTop Microbiol Immunol: 164;
143-67.
Skowronski J et al. (1990). Determinants of the B-cell
response against a transgenic autoantigen. Proc Natl Acad
Sci USA: (í prentun).
Solimena M et al. (1989). Autoantibodies to GABA-ergic
neurons and pancreatic beta ceils in stiff-man syndrome. N
Engl J Med: 322; 1555-60.
Todd JA et al. (1988). A molecular basis for MHC class II-
associated autoimmunity. Science: 240; 1003-9.
Todd JA (1990). Genetic control of autoimmunity in type I
diabetes. Immunol Today: 11; 122-9.
Vanderbark AA, Hashim G, Offner H (1989). Immunization
with a synthetic T-cell receptor V-region protects against
experimental autoimmune encephalomyelitis. Nature: 341;
541-4.
Waldmann H (1989). Manipulation of T-cell responses with
monoclonal antibodies. Annu Rev Immunol: 7; 407-44.
Wraith DC et al. (1989). T-cell recognition as the target for
immune intervention in autoimmune disease. Cell: 57; 709-
l.953vinn.«
vinn. & kr- 2'
ákr.2.00<
aukavinn.
t08 vinn.
.00. 234

HÁSKÓLA ÍSLANDS
vænlegast til vinnings
HAPPDRÆTTI
LÆKNANEMINN 1 1990 43. árg.
51